Insight

Olubukola Ayodele: Critical Discussion on Cancer Health Disparities at the House of Commons

Olubukola Ayodele/LinkedIn

Oct 15, 2024, 17:16

Olubukola Ayodele: Critical Discussion on Cancer Health Disparities at the House of Commons

Olubukola Ayodele, Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, shared on LinkedIn:

“Join us for a Critical Discussion on Cancer Health Disparities at the House of Commons!

Date: 15th November 2024
Time: 08:30 AM – 5:00 PM
Location: House of Commons, London

We cordially extend an invitation to a significant event focusing on Cancer Health Disparities.

This event aims to convene healthcare professionals, policymakers, researchers, and patient advocates to collectively address the pressing inequalities in cancer care across underserved groups.

Why Attend?

– Gain insights into the latest research on cancer disparities and their impact on diverse communities.
– Engage with influential leaders in healthcare and government who are actively driving change.
– Network with professionals committed to advancing health equity in cancer care.

Key Topics:

– Understanding and addressing barriers to cancer prevention, diagnosis, and treatment in underserved communities.
– Exploring innovative strategies to reduce disparities and improve outcomes for all.
– Discussion of policy solutions for ensuring equitable access to cancer care.

This event provides a unique opportunity to participate in constructive conversations that will shape the future of cancer care in our communities.

Let’s collaborate to bridge the gaps in cancer outcomes and strive for better health for everyone, regardless of their background.

We will also be revealing the winner of the esteemed Vanessa Moss Prize!

Take advantage of this event!

We look forward to seeing you there!

Dr. Olubukola Ayodele
Chair, Steering Committee.”

Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, specializing in breast and genitourinary malignancies, including germ cell tumors. She is also an honorary Senior Lecturer at the University of Leicester and heads the Breast Cancer Clinical Trials Unit at the Leicester Cancer Research Centre. Dr. Ayodele’s work includes numerous publications, clinical trials, and collaborative research projects on molecular drivers and biomarkers in breast cancer. She is a member of ASCO, ESMO, ACP and UKBCG.